How does a finding of low level microsatellite instability (MSI-low) in colorectal cancer change your management?
Do you treat with standard of care therapy for microsatellite stable (MSS) colorectal cancers or pursue further work-up? Does this differ between adjuvant and metastatic settings?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Duke University School of Medicine
Answered on
I currently treat MSI-low the same as MMS, regardless of whether the treatment is in the adjuvant or metastatic setting.
Join for free or sign in to see the full answer